Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers

Nutritional Neuroscience

Volumn 16, Issue 1, 2013, Pages 30-38

  Johnston, Daniel T ^a   Deuster, Patricia A ^b   Harris, William S ^c,d   MacRae, Holden ^e   Dretsch, Michael N ^f  

^a Headquarters Department of the Army ^*  (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d ERM   (United States)

^e PEPPERDINE UNIVERSITY   (United States)

^f U S ARMY AEROMEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Brain; Military; Neurocognition; Omega 3; Omega 3 index; Performance

Indexed keywords

ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; ANXIETY; ARTICLE; ATTENTION; COGNITION; COMBAT EXPERIENCES SCALE; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC TEST; DRIED BLOOD SPOT TESTING; EPWORTH SLEEPINESS SCALE; ERYTHROCYTE LEVEL; EXECUTIVE FUNCTION; FEMALE; HUMAN; IRAQ; MALE; MILITARY DEPLOYMENT; NEUROPSYCHOLOGICAL TEST; PATIENT HEALTH QUESTIONNAIRE 9; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RESPONSE TIME; SLEEP DISORDER; SOLDIER; UNITED STATES; ZUNG ANXIETY SCALE; ZUNG DEPRESSION SCALE;

EID: 84873179003     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830512Y.0000000025     Document Type: Article

References (67)

1. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems and barriers to care. US Army Med Dep J 2008:7-17.
2. Luxton DD, Skopp NA, Maguen S. Gender differences in depression and PTSD symptoms following combat exposure. Depress Anxiety 2010;27(11):1027-33.
3. Polusny MA, Kehle SM, Nelson NW, Erbes CR, Arbisi PA, Thuras P. Longitudinal effects of mild traumatic brain injury and posttraumatic stress disorder comorbidity on postdeployment outcomes in national guard soldiers deployed to Iraq. Arch Gen Psychiatry 2011;68(1):79-89.
4. Riviere LA, Kendall-Robbins A, McGurk D, Castro CA, Hoge CW. Coming home may hurt: risk factors for mental ill health in US reservists after deployment in Iraq. Br J Psychiatry 2011; 198(2):136-42.
5. Bray RM, Pemberton MR, Lane ME, Hourani LL, Mattiko MJ, Babeu LA. Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010;175(6):390-9.
6. Esposito-Smythers C, Wolff J, Lemmon KM, Bodzy M, Swenson RR, Spirito A., Military youth and the deployment cycle: Emotional health consequences and recommendations for intervention. J Fam Psychol 2011;25(4):497-507.
7. Ozias MK, Carlson SE, Levant B. Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J Nutr 2007;137(1):125-9.
8. Suganuma H, Arai Y, Kitamura Y, Hayashi M, Okumura A, Shimizu T. Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. Neuropathology 2010;30(6): 597-605.
9. Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, Visser I, et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 2010;5(5):e10635.
10. Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci. 2011;14(3): 345-50.
11. Lucas M, Kirmayer LJ, Dery S, Dewailly E. Erythrocyte n-3 is inversely correlated with serious psychological distress among the Inuit: data from the Nunavik health survey. J Am Coll Nutr 2010;29(3):211-21.
12. Milte CM, Sinn N, Street SJ, Buckley JD, Coates AM, Howe PR. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011;84(5-6):153-61.
13. Oddy WH, Hickling S, Smith MA, AOS T, Robinson M, HdK N, et al. Dietary intake of omega-3 fatty acids and risk of depressive symptoms in adolescents. Depress Anxiety 2011; 28(7):582-8.
14. Owen C, Rees AM, Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr Opin Psychiatry 2008;21(1):19-24.
15. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009;28(5):525-42.
16. Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011;72(12):1577-84.
17. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008;11(2):75-83.
18. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010;6(6):456-64.
19. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71(1 Suppl.):179S-88S.
20. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39(1):212-20.
21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9): 606-13.
22. Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ. Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in Older Americans. J Nutr 2012; In Press.
23. Gualtieri CT, Johnson LG., Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 2006;21(7):623-43.
24. Han DH, Park HW, Kee BS, Na C, Na DH, Zaichkowsky L. Performance enhancement with low stress and anxiety modulated by cognitive flexibility. Psychiatry Investig 2011;8(3):221-6.
25. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol 2000;41(1):49-100.
26. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2): 193-213.
27. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45(1 Spec No.):5-13.
28. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 2002;53(3):737-40.
29. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15(4):376-81.
30. Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994;17(8):703-10.
31. Biggs JT, Wylie LT, Ziegler VE. Validity of the Zung Self-rating Depression Scale. Br J Psychiatry 1978;132:381-5.
32. Romera I, Delgado-Cohen H, Perez T, Caballero L, Gilaberte I. Factor analysis of the Zung self-rating depression scale in a large sample of patients with major depressive disorder in primary care. BMC Psychiatry 2008;8:4.
33. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965;13(6):508-15.
34. Mikesell RH, Calhoun LG. Response set on the Zung Self- Rating Depression Scale. Percept Mot Skills 1970;30(1):22.
35. Zung WW. The differentiation of anxiety and depressive disorders: a biometric approach. Psychosomatics 1971;12(6):380-4.
36. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971;12(6):371-9.
37. Vogt DS, Proctor SP, King DW, King LA, Vasterling JJ. Validation of scales from the Deployment Risk and Resilience Inventory in a sample of Operation Iraqi Freedom veterans. Assessment 2008;15(4):391-403.
38. Lemke SL, Vicini JL, Su H, Goldstein DA, Nemeth MA, Krul ES, et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 2010;92(4):766-75.
39. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 2009;302(15):1651-7.
40. Block RC, Harris WS, Pottala JV. Determinants of Blood Cell Omega-3 Fatty Acid Content. Open Biomark J 2008;1:1-6.
41. Sands SA, Reid KJ, Windsor SL, Harris WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005;40(4):343-7.
42. Lucas M, Mirzaei F, O'Reilly EJ, Pan A, Willett WC, Kawachi I, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr 2011;93(6):1337-43.
43. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010;68(2):140-7.
44. Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 2009;25(10):1011-9.
45. Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 2008;70(8):856-62.
46. Gao Q, Niti M, Feng L, Yap KB, Ng TP. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies. J Nutr Health Aging 2011;15(1):32-5.
47. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008;71(6):430-8.
48. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012;78:658-64.
49. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001;40(1-2):1-94.
50. Pascoe MC, Crewther SG, Carey LM, Crewther DP. What you eat is what you are - a role for polyunsaturated fatty acids in neuroinflammationinduced depression? Clin Nutr 2011;30(4):407-15.
51. Uauy R, Peirano P, Hoffman D, Mena P, Birch D, Birch E. Role of essential fatty acids in the function of the developing nervous system. Lipids 1996;(31 Suppl.):S167-76.
52. Connor WE, Neuringer M, Reisbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 1992;50(4 (Pt 2)):21-9.
53. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007;137(4):855-9.
54. Moriguchi T, Salem N, Jr. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 2003; 87(2):297-309.
55. Tassoni D, Kaur G, Weisinger RS, Sinclair AJ. The role of eicosanoids in the brain. Asia Pac J Clin Nutr 2008;17(Suppl. 1): 220-8.
56. Bailes JE, Mills JD. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J Neurotrauma 2010;27(9):1617-24.
57. Bistrian BR, Askew W, Erdman JW, Jr, Oria MP. Nutrition and traumatic brain injury: a perspective from the Institute of Medicine report. JPEN J Parenter Enteral Nutr 2011;35(5): 556-9.
58. Mills JD, Bailes JE, Sedney CL, Hutchins H, Sears B. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg 2011;114(1): 77-84.
59. Mills JD, Hadley K, Bailes JE. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 2011;68(2):474-81; discussion 81.
60. IOM. (Institute of Medicine). Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Health Outcomes in Military Personnel. Washington, DC: The National Academies Press; 2011.
61. Srygley JM, Mirelman A, Herman T, Giladi N, Hausdorff JM. When does walking alter thinking? Age and task associated findings. Brain Res 2009;1253:92-9.
62. Hayashino Y, Yamazaki S, Takegami M, Nakayama T, Sokejima S, Fukuhara S. Association between number of comorbid conditions, depression, and sleep quality using the Pittsburgh Sleep Quality Index: results from a population-based survey. Sleep Med 2010;11(4):366-71.
63. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res 2011;190:53-68.
64. Jugovac D, Cavallero C. Twenty-four hours of total sleep deprivation selectively impairs attentional networks. Exp Psychol 2011;1:11-9
65. Lyche P, Jonassen R, Stiles TC, Ulleberg P, Landro NI. Verbal memory functions in unipolar major depression with and without co-morbid anxiety. Clin Neuropsychol 2011;25(3): 359-75.
66. Najmi S, Kuckertz JM, Amir N. Attentional impairment in anxiety: inefficiency in expanding the scope of attention. Depress Anxiety 2011;29(3):243-9.
67. Thoma P, Zalewski I, von Reventlow HG, Norra C, Juckel G, Daum I. Cognitive and affective empathy in depression linked to executive control. Psychiatry Res 2011;189(3):373-8.